Dexmedetomidine Infusion During Laparoscopic Adrenalectomy

• Status: Completed
• Trial end date: 2021-03-26
• Target enrollment: 0
• Participant gender: All

Summary

The investigators planned this study to investigate the effects of dexmedetomidine administration on intraoperative hemodynamic stability in patients with pheochromocytoma.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Yonsei University
• Treatments: Dexmedetomidine

Criteria

Inclusion Criteria:

1. ages of 20 and 70

2. American Society of Anesthesiologists(ASA) physical status classification I to III,

3. planned laparoscopic adrenalectomy for pheochromocytoma.

Exclusion Criteria:

1. emergency operation,

2. re-operation,

3. combined surgery with other departments,

4. body mass index (BMI) >32 kg/m2,

5. history of arrhythmias (especially AV nodal block) and ventricular conduction abnormalities,

6. uncontrolled hypertension (diastolic blood pressure >110mmHg)

7. bradycardia (heart rate < 40 beats per minute),

8. history of heart failure, hepatic and/or renal failure,

9. history of cerebrovascular disease (cerebral hemorrhage, cerebral ischemia),

10. history of beta-blocker therapy, 10) history of uncontrolled psychiatric disease.